David P Andrew

Title: David P Andrew: Innovator in Cytokine-Like Polypeptides

Introduction

David P Andrew is a notable inventor based in Branford, CT (US). He has made significant contributions to the field of biotechnology, particularly in the development of novel polypeptides. His work has implications for the detection and treatment of various pathological states.

Latest Patents

David P Andrew holds a patent for a WNT-regulated cytokine-like polypeptide and nucleic acids encoding the same. The present invention provides novel polypeptides, termed FCTRX polypeptides, as well as polynucleotides encoding FCTRX polypeptides and antibodies that immunospecifically bind to an FCTRX or a derivative, variant, mutant, or fragment of an FCTRX polypeptide, polynucleotide, or antibody. The invention additionally provides methods in which the FCTRX polypeptide, polynucleotide, and antibody are used in detection and treatment of a broad range of pathological states, as well as to other uses. He has 1 patent to his name.

Career Highlights

Throughout his career, David P Andrew has worked with prominent companies in the biotechnology sector. He has been associated with Curagen Corporation and Genentech, Inc., where he contributed to various innovative projects. His expertise in the field has allowed him to make impactful advancements in biotechnology.

Collaborations

David P Andrew has collaborated with notable colleagues, including David A Lewin and Diane Pennica. These collaborations have further enriched his work and contributed to the success of his inventions.

Conclusion

David P Andrew is a distinguished inventor whose work in cytokine-like polypeptides has the potential to revolutionize the detection and treatment of diseases. His contributions to biotechnology continue to inspire future innovations in the field.